Detalles de la búsqueda
1.
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Breast Cancer Res
; 21(1): 39, 2019 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867034
2.
Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.
Oncologist
; 24(1): e30-e37, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30181313
3.
Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia.
J Hum Genet
; 64(4): 281-290, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30651582
4.
Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 19(7): 987-998, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880292
5.
Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE.
J BUON
; 23(2): 522-532, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29745102
6.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(12): 1688-1700, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146401
7.
Prognostic importance of steroid receptor status for disease free and overall survival after surgical resection of isolated liver metastasis in breast cancer patients.
J BUON
; 22(1): 192-199, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28365954
8.
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.
Oncologist
; 21(10): 1183-1190, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27401890
9.
Early prognosis of metastasis risk in inflammatory breast cancer by texture analysis of tumour microscopic images.
Biomed Microdevices
; 17(5): 92, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26286863
10.
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
J Neurooncol
; 122(1): 205-16, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25559688
11.
Gray-Level Co-Occurrence Matrix Texture Analysis of Breast Tumor Images in Prognosis of Distant Metastasis Risk.
Microsc Microanal
; 21(3): 646-54, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25857827
12.
Oral administration of antineoplastic agents: the challenges for healthcare professionals.
J BUON
; 20(3): 690-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26214619
13.
Breast cancer and recurrent thrombosis - Results from prospective single center study.
Breast J
; 25(4): 783-785, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079419
14.
Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review.
Int J Gynecol Cancer
; 23(5): 823-32, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23666016
15.
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Eur J Cancer
; 184: 48-59, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898233
16.
White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome.
Pathol Res Pract
; 224: 153543, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34273805
17.
Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study.
Drug Saf
; 43(3): 233-242, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31927716
18.
Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
Int J Biol Markers
; 31(3): e258-63, 2016 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26954070
19.
Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
Eur J Intern Med
; 26(1): 63-7, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592075
20.
RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women.
Fam Cancer
; 13(2): 173-80, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24114315